News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Greenleaf Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Greenleaf Peter (CEO) has filed a Form 4 on Aurinia Pharmaceuticals Inc.|
Txns:
| Granted 667,407 shares
@ $0
Sold 32,750 shares
@ $8.94, valued at
$292.8k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| Greenleaf Peter (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 105,034 shares
@ $0
Disposed/sold 27,746 restricted stock units
@ $0
Disposed/sold 64,164 options to buy
@ $2.93, valued at
$188k
Disposed/sold 114,347 options to buy
@ $3.66, valued at
$418.5k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Greenleaf Peter (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 114,347 options to buy
@ $3.66, valued at
$418.5k
Granted 20,492 restricted stock units
@ $0
Exercised 10,246 restricted stock units
@ $0 |
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Greenleaf Peter (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Granted 30,220 shares
@ $2.73, valued at
$82.5k
Granted 58,246 options to buy
@ $2.73, valued at
$159k
|
|
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2019 |
4
| Greenleaf Peter (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 21,144 restricted stock units
@ $0 |
|
| 06/14/2019 |
4
| Greenleaf Peter (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Granted 23,973 shares
@ $2.92, valued at
$70k
Granted 46,729 options to buy
@ $2.92, valued at
$136.4k
|
|
| 05/29/2019 |
4
| Greenleaf Peter (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Disposed/sold 300,000 shares
@ $0
Disposed/sold 325,000 options to buy
@ $6.22, valued at
$2M
Disposed/sold 364,583 options to buy
@ $4.24, valued at
$1.5M
Disposed/sold 500,000 options to buy
@ $4.24, valued at
$2.1M
|
|
| 04/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2018 |
4
| Greenleaf Peter (Director) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Granted 20,000 options to buy
@ $3.11, valued at
$62.2k
|
|
| 08/16/2018 |
4
| Greenleaf Peter (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 3,644 restricted stock units
@ $0 |
|
| 08/08/2018 |
4
| Greenleaf Peter (Director) has filed a Form 4 on EYEGATE PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $0.57, valued at
$28.5k
|
|
| 08/03/2018 |
4
| Greenleaf Peter (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 112,288 restricted stock units
@ $0
Granted 64,164 options to buy
@ $2.93, valued at
$188k
|
|
| 05/21/2018 |
4
| Greenleaf Peter (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Bought 12,500 shares
@ $3.98, valued at
$49.8k
|
|
| 03/29/2018 |
4
| Greenleaf Peter (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 400,000 shares
@ $0
Granted 500,000 options to buy
@ $4.24, valued at
$2.1M
|
|
| 02/13/2018 |
4
| Greenleaf Peter (CEO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 129,729 shares
@ $18, valued at
$2.3M
Disposed/sold 600,000 options to buy
@ $8.49, valued at
$5.1M
Disposed/sold 200,000 options to buy
@ $5.9, valued at
$1.2M
Disposed/sold 210,000 options to buy
@ $14.82, valued at
$3.1M
Disposed/sold 420,000 options to buy
@ $13.8, valued at
$5.8M
Disposed/sold 237,000 options to buy
@ $11.85, valued at
$2.8M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|